Japanese
English

Light at the End of the Tunnel

Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.

News Releases

May. 01 2026 Restore Vision Announces First-in-Human Clinical Interim Results for RV-001, a GPCR-Based Optogenetic Gene Therapy

Apr. 15 2026 Restore Vision Secures JPY 1.3 Billion in Pre-Series B Financing, Bringing Total Funding to More Than JPY 5.8 Billion Including Grants

Feb. 13 2025 Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

Read More